Prostaglandins (PG) are very potent mediators which can dilate or constrict the bronchi. In order to evaluate the role of PG in the homeostasis of bronchial tone, we studied the effects of mefenamic acid, a potent cyclooxygenase inhibitor, on the pulmonary function tests of 20 volunteers. The subjects were studied randomly in two sessions, one with a placebo and one with mefenamic acid. Tablets (drug or placebo) were taken for 2 days with the pulmonary function tests performed in the afternoon of the second day. Sessions were performed at least 2 days apart. Parameters measured, including forced vital capacity, forced expiratory volume in 1 s, expiratory flows, functional residual capacity and specific airway conductance (SGaw), were similar in both sessions. The SGaw, which was previously reported to increase with cyclooxygenase inhibitors, was 0.23 ± 0.06 s-1 • cm H2O-1 in the placebo session and 0.24 ± 0.06 in the mefenamic acid session (mean ± SD). This study shows that cyclooxygenase inhibitors have no effect on airway tone and strongly suggests that endogenous PG do not participate in the homeostasis of normal bronchial tone.

Keywords:
Anti-inflammatory agents, Prostaglandins, Bronchial tone
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.